GenMark Shares Spike on Appointment of New CEO | GenomeWeb

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Shares of GenMark Diagnostics jumped 18 percent on Wednesday after the firm announced that it had appointed a new CEO.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.